Aspen Aerogels (ASPN) Equity Average (2014 - 2026)

Aspen Aerogels has reported Equity Average for 13 years, with the latest figure at $224.5 million in Q1 2026.

• For the quarter ending Q1 2026, Equity Average fell 51.69% year-over-year to $224.5 million; the trailing twelve-month figure through Mar 2026 stood at $224.5 million (down 51.69% YoY), and the FY2025 full-year result was $425.1 million, down 22.9% from the prior year.
• Equity Average for Q1 2026 stood at $224.5 million, down from $270.6 million in the prior quarter.
• The five-year high for Equity Average was $561.2 million in Q4 2024, with the low at $155.0 million in Q1 2022.
• Historically, Equity Average has averaged $364.3 million across 5 years, with a median of $414.9 million in 2023.
• Annual changes were most pronounced in 2023 — Equity Average jumped 183.85% — and 2025, when it slumped 51.78%.
• Aspen Aerogels' Equity Average stood at $314.9 million in 2022, then jumped by 42.55% to $448.9 million in 2023, then gained by 25.0% to $561.2 million in 2024, then tumbled by 51.78% to $270.6 million in 2025, then fell by 17.04% to $224.5 million in 2026.
• The last three Equity Average figures came in at $224.5 million (Q1 2026), $270.6 million (Q4 2025), and $307.3 million (Q3 2025), per Business Quant data.